Logo Logo
Hilfe
Hilfe
Switch Language to English

Zeuner, Kirsten L.; Schaeffer, Eva; Hopfner, Franziska; Brueggemann, Norbert und Berg, Daniela (2019): Progress of Pharmacological Approaches in Parkinson's Disease. In: Clinical Pharmacology & Therapeutics, Bd. 105, Nr. 5: S. 1106-1120

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

The progressive neurodegenerative process in Parkinson's disease (PD) is not restricted to dopaminergic midbrain neurons but involves the entire nervous system. In this review, we outline established treatment options at different disease stages and address new therapeutic approaches. These include, based on recent advances in the understanding of the pathophysiology of PD, genetic and disease-modifying approaches to reduce abnormal accumulation and aggregation of alpha-synuclein (aSYN), mitochondrial dysfunction, and dysfunction of lysosomal proteins. Moreover, we highlight clinical trials to reduce neuroinflammation and increase neurorestoration.

Dokument bearbeiten Dokument bearbeiten